These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 32890025)
1. Molecular alterations in meningioma: prognostic and therapeutic perspectives. Birzu C; Peyre M; Sahm F Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025 [TBL] [Abstract][Full Text] [Related]
2. Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets. Maggio I; Franceschi E; Di Nunno V; Gatto L; Tosoni A; Angelini D; Bartolini S; Lodi R; Brandes AA Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679551 [TBL] [Abstract][Full Text] [Related]
3. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175 [TBL] [Abstract][Full Text] [Related]
4. Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas. Cordova C; Kurz SC Curr Oncol Rep; 2020 Jul; 22(8):84. PubMed ID: 32617743 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of genetic alterations and methylation classes in meningioma. Berghoff AS; Hielscher T; Ricken G; Furtner J; Schrimpf D; Widhalm G; Rajky U; Marosi C; Hainfellner JA; von Deimling A; Sahm F; Preusser M Brain Pathol; 2022 Mar; 32(2):e12970. PubMed ID: 35213082 [TBL] [Abstract][Full Text] [Related]
6. Biology and clinical management challenges in meningioma. Mawrin C; Chung C; Preusser M Am Soc Clin Oncol Educ Book; 2015; ():e106-15. PubMed ID: 25993161 [TBL] [Abstract][Full Text] [Related]
7. Genomic Landscape of Meningiomas. Wang JZ; Nassiri F; Mawrin C; Zadeh G Adv Exp Med Biol; 2023; 1416():137-158. PubMed ID: 37432625 [TBL] [Abstract][Full Text] [Related]
8. Meningioma: current updates on genetics, classification, and mouse modeling. Szulzewsky F; Thirimanne HN; Holland EC Ups J Med Sci; 2024; 129():. PubMed ID: 38571886 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Abedalthagafi M; Bi WL; Aizer AA; Merrill PH; Brewster R; Agarwalla PK; Listewnik ML; Dias-Santagata D; Thorner AR; Van Hummelen P; Brastianos PK; Reardon DA; Wen PY; Al-Mefty O; Ramkissoon SH; Folkerth RD; Ligon KL; Ligon AH; Alexander BM; Dunn IF; Beroukhim R; Santagata S Neuro Oncol; 2016 May; 18(5):649-55. PubMed ID: 26826201 [TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of meningiomas: Building the roadmap towards personalized therapy. Peyre M; Kalamarides M Neurochirurgie; 2018 Mar; 64(1):22-28. PubMed ID: 25245924 [TBL] [Abstract][Full Text] [Related]
15. Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT. Jungwirth G; Warta R; Beynon C; Sahm F; von Deimling A; Unterberg A; Herold-Mende C; Jungk C Acta Neuropathol Commun; 2019 Aug; 7(1):140. PubMed ID: 31470906 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management. Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040 [TBL] [Abstract][Full Text] [Related]
17. Current treatment options for meningioma. Apra C; Peyre M; Kalamarides M Expert Rev Neurother; 2018 Mar; 18(3):241-249. PubMed ID: 29338455 [TBL] [Abstract][Full Text] [Related]
18. SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas. Boetto J; Bielle F; Sanson M; Peyre M; Kalamarides M Neuro Oncol; 2017 Mar; 19(3):345-351. PubMed ID: 28082415 [TBL] [Abstract][Full Text] [Related]
19. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Reuss DE; Piro RM; Jones DT; Simon M; Ketter R; Kool M; Becker A; Sahm F; Pusch S; Meyer J; Hagenlocher C; Schweizer L; Capper D; Kickingereder P; Mucha J; Koelsche C; Jäger N; Santarius T; Tarpey PS; Stephens PJ; Andrew Futreal P; Wellenreuther R; Kraus J; Lenartz D; Herold-Mende C; Hartmann C; Mawrin C; Giese N; Eils R; Collins VP; König R; Wiestler OD; Pfister SM; von Deimling A Acta Neuropathol; 2013 Mar; 125(3):351-8. PubMed ID: 23404370 [TBL] [Abstract][Full Text] [Related]
20. Clinical potential of meningioma genomic insights: a practical review for neurosurgeons. Karsy M; Azab MA; Abou-Al-Shaar H; Guan J; Eli I; Jensen RL; Ormond DR Neurosurg Focus; 2018 Jun; 44(6):E10. PubMed ID: 29852774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]